213 related articles for article (PubMed ID: 24556997)
1. Phospholipase D1 and choline kinase-α are interactive targets in breast cancer.
Gadiya M; Mori N; Cao MD; Mironchik Y; Kakkad S; Gribbestad IS; Glunde K; Krishnamachary B; Bhujwalla ZM
Cancer Biol Ther; 2014 May; 15(5):593-601. PubMed ID: 24556997
[TBL] [Abstract][Full Text] [Related]
2. Choline kinase-α protein and phosphatidylcholine but not phosphocholine are required for breast cancer cell survival.
Mori N; Wildes F; Kakkad S; Jacob D; Solaiyappan M; Glunde K; Bhujwalla ZM
NMR Biomed; 2015 Dec; 28(12):1697-706. PubMed ID: 26503172
[TBL] [Abstract][Full Text] [Related]
3. Molecular Effects of Doxorubicin on Choline Metabolism in Breast Cancer.
Cheng M; Rizwan A; Jiang L; Bhujwalla ZM; Glunde K
Neoplasia; 2017 Aug; 19(8):617-627. PubMed ID: 28654865
[TBL] [Abstract][Full Text] [Related]
4. Glycerophosphodiester phosphodiesterase domain containing 5 (GDPD5) expression correlates with malignant choline phospholipid metabolite profiles in human breast cancer.
Cao MD; Döpkens M; Krishnamachary B; Vesuna F; Gadiya MM; Lønning PE; Bhujwalla ZM; Gribbestad IS; Glunde K
NMR Biomed; 2012 Sep; 25(9):1033-42. PubMed ID: 22279038
[TBL] [Abstract][Full Text] [Related]
5. Choline kinase down-regulation increases the effect of 5-fluorouracil in breast cancer cells.
Mori N; Glunde K; Takagi T; Raman V; Bhujwalla ZM
Cancer Res; 2007 Dec; 67(23):11284-90. PubMed ID: 18056454
[TBL] [Abstract][Full Text] [Related]
6. Characterization of choline kinase in human endothelial cells.
Mori N; Gadiya M; Wildes F; Krishnamachary B; Glunde K; Bhujwalla ZM
NMR Biomed; 2013 Nov; 26(11):1501-7. PubMed ID: 23775813
[TBL] [Abstract][Full Text] [Related]
7. Noninvasive detection of lentiviral-mediated choline kinase targeting in a human breast cancer xenograft.
Krishnamachary B; Glunde K; Wildes F; Mori N; Takagi T; Raman V; Bhujwalla ZM
Cancer Res; 2009 Apr; 69(8):3464-71. PubMed ID: 19336572
[TBL] [Abstract][Full Text] [Related]
8. Choline kinase overexpression increases invasiveness and drug resistance of human breast cancer cells.
Shah T; Wildes F; Penet MF; Winnard PT; Glunde K; Artemov D; Ackerstaff E; Gimi B; Kakkad S; Raman V; Bhujwalla ZM
NMR Biomed; 2010 Jul; 23(6):633-42. PubMed ID: 20623626
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of Choline Kinase-Alpha Enhances Autophagy in Tamoxifen-Resistant Breast Cancer Cells.
Kim HS; Tian L; Jung M; Choi SK; Sun Y; Kim H; Moon WK
PLoS One; 2015; 10(10):e0141110. PubMed ID: 26496360
[TBL] [Abstract][Full Text] [Related]
10. Selective inhibition of choline kinase simultaneously attenuates MAPK and PI3K/AKT signaling.
Yalcin A; Clem B; Makoni S; Clem A; Nelson K; Thornburg J; Siow D; Lane AN; Brock SE; Goswami U; Eaton JW; Telang S; Chesney J
Oncogene; 2010 Jan; 29(1):139-49. PubMed ID: 19855431
[TBL] [Abstract][Full Text] [Related]
11. Molecular causes of the aberrant choline phospholipid metabolism in breast cancer.
Glunde K; Jie C; Bhujwalla ZM
Cancer Res; 2004 Jun; 64(12):4270-6. PubMed ID: 15205341
[TBL] [Abstract][Full Text] [Related]
12. Activation of phosphatidylcholine cycle enzymes in human epithelial ovarian cancer cells.
Iorio E; Ricci A; Bagnoli M; Pisanu ME; Castellano G; Di Vito M; Venturini E; Glunde K; Bhujwalla ZM; Mezzanzanica D; Canevari S; Podo F
Cancer Res; 2010 Mar; 70(5):2126-35. PubMed ID: 20179205
[TBL] [Abstract][Full Text] [Related]
13. PLD1 is overexpressed in an ER-negative MCF-7 cell line variant and a subset of phospho-Akt-negative breast carcinomas.
Gozgit JM; Pentecost BT; Marconi SA; Ricketts-Loriaux RS; Otis CN; Arcaro KF
Br J Cancer; 2007 Sep; 97(6):809-17. PubMed ID: 17726467
[TBL] [Abstract][Full Text] [Related]
14. Characterization of breast cancers and therapy response by MRS and quantitative gene expression profiling in the choline pathway.
Morse DL; Carroll D; Day S; Gray H; Sadarangani P; Murthi S; Job C; Baggett B; Raghunand N; Gillies RJ
NMR Biomed; 2009 Jan; 22(1):114-27. PubMed ID: 19016452
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia regulates choline kinase expression through hypoxia-inducible factor-1 alpha signaling in a human prostate cancer model.
Glunde K; Shah T; Winnard PT; Raman V; Takagi T; Vesuna F; Artemov D; Bhujwalla ZM
Cancer Res; 2008 Jan; 68(1):172-80. PubMed ID: 18172309
[TBL] [Abstract][Full Text] [Related]
16. Noninvasive imaging identifies new roles for cyclooxygenase-2 in choline and lipid metabolism of human breast cancer cells.
Shah T; Stasinopoulos I; Wildes F; Kakkad S; Artemov D; Bhujwalla ZM
NMR Biomed; 2012 May; 25(5):746-54. PubMed ID: 21953546
[TBL] [Abstract][Full Text] [Related]
17. Alterations of choline phospholipid metabolism in ovarian tumor progression.
Iorio E; Mezzanzanica D; Alberti P; Spadaro F; Ramoni C; D'Ascenzo S; Millimaggi D; Pavan A; Dolo V; Canevari S; Podo F
Cancer Res; 2005 Oct; 65(20):9369-76. PubMed ID: 16230400
[TBL] [Abstract][Full Text] [Related]
18. Autoregulation of phospholipase D activity is coupled to selective induction of phospholipase D1 expression to promote invasion of breast cancer cells.
Kang DW; Park MH; Lee YJ; Kim HS; Lindsley CW; Alex Brown H; Min do S
Int J Cancer; 2011 Feb; 128(4):805-16. PubMed ID: 20473892
[TBL] [Abstract][Full Text] [Related]
19. Anterior gradient-2 plays a critical role in breast cancer cell growth and survival by modulating cyclin D1, estrogen receptor-alpha and survivin.
Vanderlaag KE; Hudak S; Bald L; Fayadat-Dilman L; Sathe M; Grein J; Janatpour MJ
Breast Cancer Res; 2010; 12(3):R32. PubMed ID: 20525379
[TBL] [Abstract][Full Text] [Related]
20. Distinct choline metabolic profiles are associated with differences in gene expression for basal-like and luminal-like breast cancer xenograft models.
Moestue SA; Borgan E; Huuse EM; Lindholm EM; Sitter B; Børresen-Dale AL; Engebraaten O; Maelandsmo GM; Gribbestad IS
BMC Cancer; 2010 Aug; 10():433. PubMed ID: 20716336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]